InMode Ltd (INMD) - Net Assets

Latest as of December 2025: $683.20 Million USD

Based on the latest financial reports, InMode Ltd (INMD) has net assets worth $683.20 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($766.43 Million) and total liabilities ($83.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INMD financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $683.20 Million
% of Total Assets 89.14%
Annual Growth Rate 61.55%
5-Year Change 64.31%
10-Year Change N/A
Growth Volatility 90.37

InMode Ltd - Net Assets Trend (2016–2025)

This chart illustrates how InMode Ltd's net assets have evolved over time, based on quarterly financial data. Also explore total assets of InMode Ltd for the complete picture of this company's asset base.

Annual Net Assets for InMode Ltd (2016–2025)

The table below shows the annual net assets of InMode Ltd from 2016 to 2025. For live valuation and market cap data, see INMD company net worth.

Year Net Assets Change
2025-12-31 $683.20 Million -2.93%
2024-12-31 $703.81 Million -10.61%
2023-12-31 $787.37 Million +41.97%
2022-12-31 $554.62 Million +33.39%
2021-12-31 $415.80 Million +62.76%
2020-12-31 $255.47 Million +42.09%
2019-12-31 $179.80 Million +302.46%
2018-12-31 $44.68 Million +129.66%
2017-12-31 $19.45 Million +113.30%
2016-12-31 $9.12 Million --

Equity Component Analysis

This analysis shows how different components contribute to InMode Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 30608.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $968.53 Million 141.76%
Total Equity $683.20 Million 100.00%

InMode Ltd Competitors by Market Cap

The table below lists competitors of InMode Ltd ranked by their market capitalization.

Company Market Cap
Capitol Federal Financial Inc
NASDAQ:CFFN
$910.87 Million
SpartanNash Co
NASDAQ:SPTN
$910.90 Million
Qingmu Digital Technology Co.Ltd.
SHE:301110
$911.03 Million
Sonaecom SGPS
LS:SNC
$911.19 Million
Hangzhou Fortune Gas Cryogenic Group Co. Ltd. A
SHG:603173
$910.77 Million
Tianjin Tianyao Pharmaceuticals Co Ltd
SHG:600488
$910.73 Million
Hana Microelectronics Public Company Limited
BK:HANA
$910.67 Million
Inventiva S.A
PA:IVA
$910.54 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in InMode Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 703,813,000 to 683,198,000, a change of -20,615,000 (-2.9%).
  • Net income of 93,831,000 contributed positively to equity growth.
  • Share repurchases of 127,444,000 reduced equity.
  • Other comprehensive income increased equity by 340,000.
  • Other factors increased equity by 12,658,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $93.83 Million +13.73%
Share Repurchases $127.44 Million -18.65%
Other Comprehensive Income $340.00K +0.05%
Other Changes $12.66 Million +1.85%
Total Change $- -2.93%

Book Value vs Market Value Analysis

This analysis compares InMode Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.34x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 86.00x to 1.34x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 $0.17 $14.41 x
2017-12-31 $0.30 $14.41 x
2018-12-31 $0.68 $14.41 x
2019-12-31 $2.31 $14.41 x
2020-12-31 $3.02 $14.41 x
2021-12-31 $4.83 $14.41 x
2022-12-31 $6.49 $14.41 x
2023-12-31 $9.16 $14.41 x
2024-12-31 $8.73 $14.41 x
2025-12-31 $10.78 $14.41 x

Capital Efficiency Dashboard

This dashboard shows how efficiently InMode Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 13.73%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 25.33%
  • • Asset Turnover: 0.48x
  • • Equity Multiplier: 1.12x
  • Recent ROE (13.73%) is below the historical average (29.85%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 3.77% 1.46% 1.40x 1.85x $-556.10K
2017 45.33% 16.50% 1.36x 2.03x $6.87 Million
2018 51.71% 22.33% 1.24x 1.87x $18.04 Million
2019 34.73% 39.11% 0.72x 1.24x $43.54 Million
2020 29.54% 36.40% 0.70x 1.16x $49.63 Million
2021 39.68% 46.14% 0.75x 1.15x $123.39 Million
2022 29.12% 35.56% 0.70x 1.16x $106.06 Million
2023 25.14% 40.22% 0.57x 1.10x $119.18 Million
2024 25.76% 45.91% 0.50x 1.12x $110.89 Million
2025 13.73% 25.33% 0.48x 1.12x $25.51 Million

Industry Comparison

This section compares InMode Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,432,799,891
  • Average return on equity (ROE) among peers: -74.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
InMode Ltd (INMD) $683.20 Million 3.77% 0.12x $910.84 Million
Abbott Laboratories (ABT) $24.16 Billion 9.46% 0.81x $155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-13.54K 0.00% 0.00x $21.60 Million
Aethlon Medical Inc (AEMD) $9.29 Million -84.45% 0.15x $2.79 Million
Acutus Medical Inc (AFIB) $105.73 Million -116.68% 0.61x $903.35K
Adapthealth Corp (AHCO) $15.14 Million -140.98% 14.05x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $2.15 Million -112.84% 0.45x $16.04 Million
Allurion Technologies, Inc. (ALUR) $-70.49 Million 0.00% 0.00x $8.60 Million
Autonomix Medical, Inc. Common Stock (AMIX) $644.00K -309.01% 0.34x $4.22 Million
Artivion Inc (AORT) $89.39 Million 8.74% 0.25x $1.73 Billion
Apyx Medical Inc (APYX) $21.15 Million 2.82% 0.30x $125.55 Million

About InMode Ltd

NASDAQ:INMD USA Medical Devices
Market Cap
$910.84 Million
Market Cap Rank
#9523 Global
#2491 in USA
Share Price
$14.41
Change (1 day)
-0.41%
52-Week Range
$12.76 - $16.62
All Time High
$97.86
About

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more